Compare ENVA & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENVA | BLLN |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | 713 |
| Industry | Finance: Consumer Services | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 3.7B |
| IPO Year | 2011 | N/A |
| Metric | ENVA | BLLN |
|---|---|---|
| Price | $168.41 | $83.72 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $173.00 | $126.71 |
| AVG Volume (30 Days) | 168.8K | ★ 380.4K |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.05 | N/A |
| EPS | ★ 11.52 | N/A |
| Revenue | ★ $3,151,653,000.00 | N/A |
| Revenue This Year | $149.64 | $46.29 |
| Revenue Next Year | $16.42 | $30.14 |
| P/E Ratio | $14.59 | ★ N/A |
| Revenue Growth | ★ 18.58 | N/A |
| 52 Week Low | $89.00 | $61.96 |
| 52 Week High | $176.68 | $138.70 |
| Indicator | ENVA | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 76.71 | 53.21 |
| Support Level | $153.44 | $79.33 |
| Resistance Level | $176.68 | $98.48 |
| Average True Range (ATR) | 4.47 | 6.77 |
| MACD | 2.66 | 0.40 |
| Stochastic Oscillator | 90.66 | 41.88 |
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.
BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.